AgomAb Therapeutics
Ohad is a Partner at Pontifax, where he is focused on scouting and project evaluation. He also serves on the board of several of Pontifax’s portfolio companies including AgomAb, Precirix, Step Pharma, Pi Therapeutics and Kamari Pharma. Ohad obtained his MSc in Biology from Tel-Aviv University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
AgomAb Therapeutics
AgomAb is pioneering therapies that modulate regenerative pathways to achieve structural tissue repair and functional organ recovery.